REDUCE Study: For patients with Elevated Left Atrial Pressure with Heart Failure
Brief description of study
This study is assessing the safety and tolerability of an interatrial septal device implanted for those who have a dilated left atrium or some degree of diastolic dysfunction. This is often known as preserved ejection fraction heart failure. This study is blinded over the course of 2 years, and there is a crossover period at the end for those who still meet criteria and who were in the control group.
Detailed description of study
Clinic visits involve physical exam, blood work, EKG, 6 minute walk test, and questionnaires.
Visits:
Screening visit in clinic
Randomization and procedure date (this would include a right heart catheterization and exercise bike, to assess hemodynamics at peak exercise)
Follow up clinic visits:
1 month
3 month
6 month
12 month
24 month
every year after that
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Cardiology,HFPEF,research,atrial fibrillation,diastolic dysfunction,dyspnea,shortness of breath,heart failure
-
Age: Between 40 Years - 100 Years
-
Gender: All
Updated on
01 Nov 2022.
Study ID: 827489